SIFI S.p.A. Sells to Faes Farma for €270 Million with Potential Future Payouts
Deal News | Jun 13, 2025 | Hogan Lovells
Hogan Lovells advised the founding shareholders and 21 Invest on the sale of SIFI S.p.A to Faes Farma. The transaction valued SIFI S.p.A at €270 million based on enterprise value, with potential additional price components linked to specific milestones. SIFI S.p.A, a specialist in pharmaceutical and medical devices for eye care, will enhance Faes Farma's market position and catalyze growth and innovation in the sector. The advisory team at Hogan Lovells was led by partner Luca Picone and was assisted by several key members for various components of the transaction.
Sectors
- Pharmaceuticals
- Medical Devices
Geography
- Italy – SIFI S.p.A. is based in Italy.
- Spain – Faes Farma, the acquiring company, is based in Spain.
- United States – Hogan Lovells provided advisory from their New York and Los Angeles offices, indicating the participation of U.S. expertise.
Industry
- Pharmaceuticals – SIFI S.p.A. operates within this industry, focusing on pharmaceutical products for eye care.
- Medical Devices – The sale highlights SIFI S.p.A.'s involvement in the production of surgical and medical devices.
Financials
- €270 million – Enterprise value of SIFI S.p.A. in the transaction with Faes Farma.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| SIFI S.p.A. | Target | Company | A company specializing in pharmaceuticals and medical devices for eye care. |
| Faes Farma | Bidding Company | Company | The acquiring pharmaceutical company. |
| Hogan Lovells | Legal Advisor | Company | The legal firm advising the sale transaction, led by Luca Picone and team. |
| Luca Picone | Lead Advisor | Person | Partner at Hogan Lovells leading the transaction advisory. |
| 21 Invest | Selling Company | Company | The private equity firm involved as shareholders of SIFI S.p.A. |